3D-011

N/A

Report date: 2026/01/07 17:37:33
NME

Base Information

Drug Name3D-011
Drug Alias Name3D-0113D011-08
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Prodrug
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsPlatelet-derived growth factor receptor inhibitors
TargetsVascular endothelial growth factor receptorPlatelet-derived growth factor receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator Companies3d Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesThinkti (Beijing) Pharmaceutical Technology Co Ltd3d Medicines Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A